Alpha DNA Investment Management LLC Purchases Shares of 2,949 Addus HomeCare Co. (NASDAQ:ADUS)

Alpha DNA Investment Management LLC bought a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the third quarter, Holdings Channel.com reports. The firm bought 2,949 shares of the company’s stock, valued at approximately $392,000.

A number of other large investors also recently modified their holdings of the stock. Texas Permanent School Fund Corp lifted its position in shares of Addus HomeCare by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock worth $1,636,000 after purchasing an additional 82 shares in the last quarter. Arizona State Retirement System raised its stake in shares of Addus HomeCare by 2.0% during the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock worth $527,000 after buying an additional 87 shares during the last quarter. UMB Bank n.a. raised its stake in shares of Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares during the last quarter. Inspire Investing LLC raised its stake in shares of Addus HomeCare by 3.3% during the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after buying an additional 100 shares during the last quarter. Finally, New York State Teachers Retirement System increased its stake in Addus HomeCare by 1.2% in the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock valued at $1,132,000 after purchasing an additional 100 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Trading Up 2.9 %

Shares of ADUS opened at $124.32 on Monday. Addus HomeCare Co. has a 12 month low of $85.43 and a 12 month high of $136.12. The firm has a fifty day simple moving average of $128.25 and a 200 day simple moving average of $123.29. The stock has a market capitalization of $2.25 billion, a price-to-earnings ratio of 28.45, a PEG ratio of 2.11 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.03 earnings per share. As a group, research analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ADUS has been the subject of several recent analyst reports. Stephens upped their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. KeyCorp initiated coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. Oppenheimer upped their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. TD Cowen upped their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Finally, Macquarie reissued an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Insider Buying and Selling at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares in the company, valued at approximately $429,165. This trade represents a 12.93 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.